CONMED Corporation
CONMED Corporation (CNMD) Stock Overview
Explore CONMED Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
22.90
EPS (TTM)
$1.51
ROE
0.05%
CNMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CONMED Corporation (CNMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 34.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.90 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.